Insulin detemir for the treatment of obese patients with type 2 diabetes

Priscilla A Hollander1,21Baylor Endocrine Center, 2Baylor Medical Center, Dallas, Texas, USAAbstract: The risk for developing type 2 diabetes (T2DM) is greater among obese individuals. Following onset of the disease, patients with T2DM become more likely to be afflicted with diabetic micro- and macr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Hollander PA
Format: article
Langue:EN
Publié: Dove Medical Press 2012
Sujets:
Accès en ligne:https://doaj.org/article/7f4d03e329264a229836c8e3fbe450cd
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!